Αποτελέσματα Αναζήτησης
6 Μαΐ 2024 · Glioblastoma multiforme (GBM) is the most malignant and pervasive subtype of glioma and is the most common primary brain tumor in adults. It remains an incurable disease with a median survival of 15 months and has been classified into wild-type and mutant isocitrate dehydrogenase (IDH) subtypes.
14 Αυγ 2024 · Glioblastoma, formerly known as glioblastoma multiforme, is a devastating type of cancer that can result in death in fewer than six months without treatment. It’s important to seek diagnosis and treatment as soon as possible to prolong your life.
Contrary to the results of the univariate analysis, multivariate analysis revealed that only grade and surgery were independent prognostic factors for GBM patients (HR = 13.812, 95% CI [3.333–57.242]; HR = 0.566, 95% CI [0.349–0.917]), but not age, radiotherapy, and chemotherapy.
Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant, primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic heterogeneity, and protection by the blood brain barrier (BBB) have posed great treatment challenges.
Glioblastoma multiforme (GBM) is the most common, aggressive form of brain cancer in adults and is universally fatal. The current standard-of-care options for GBM include surgical resection, radiotherapy, and concomitant and/or adjuvant chemotherapy.
14 Ιουλ 2021 · Glioblastoma is the most common primary brain cancer in adults. 1 Despite surgical resection, chemotherapy, and radiotherapy, median survival after diagnosis is only 14-16 months. …
1 Ιουν 2020 · Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for patients with this disease is poor, with a median survival of <2 years. There is a slight predominance in males, and incidence increases with age.
